Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Queensland Health
Fuji
Teva
Healthtrust
Dow
Daiichi Sankyo
US Army
McKesson

Generated: April 25, 2018

DrugPatentWatch Database Preview

DAYPRO Drug Profile

« Back to Dashboard

When do Daypro patents expire, and when can generic versions of Daypro launch?

Daypro is a drug marketed by Gd Searle and is included in two NDAs.

The generic ingredient in DAYPRO is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.
Drug patent expirations by year for DAYPRO
Pharmacology for DAYPRO
Synonyms for DAYPRO
.beta.-(4,5-Diphenyloxazol-2-yl)propionic acid
2-Oxazolepropanoic acid, 4,5-diphenyl-
2-Oxazolepropanoic acid,5-diphenyl-
2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL-
2-Oxazolepropionic acid,5-diphenyl-
21256-18-8
256O188
3-(4, 5-Diphenyl-2-oxazo
3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid #
3-(4,5-Diphenyl-2-oxazolyl)propanoic acid
3-(4,5-Diphenyl-2-oxazolyl)propenoic acid
3-(4,5-Diphenyl-2-oxazolyl)propionic acid
3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid
3-(4,5-Diphenyloxazol-2-yl)propanoic acid
3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
4, 5-Diphenyl-2-oxazolepropionic acid
4,5-Diphenyl-2-oxazolepropanoic acid
4,5-Diphenyl-2-oxazolepropionic acid
4,5-diphenyloxazole-2-propanoic acid
4.5-Diphenyl-2-oxazolepropanoic acid|||Daypro
A815225
AB0011812
AB00514024
AB00514024_08
AB00514024_09
AC-26512
AC1L1IK7
AC1Q759J
AC1Q759K
Actirin
AJ-08102
AK-84489
AKOS000206807
Alvo
ANW-63377
Apo-Oxaprozin
Apotex brand of oxaprozin
B1804
BDBM50002861
beta-(4,5-Diphenyloxazol-2-yl)propionic acid
BIDD:GT0438
BIDD:PXR0149
BPBio1_001122
BRD-K25394294-001-05-7
BRN 1083168
BSPBio_001020
BSPBio_002696
C07356
C18H15NO3
CAS-21256-18-8
CCG-36508
CHEBI:7822
CHEMBL1071
CPD000058286
CS-7975
CSC brand of oxaprozin
CTK7J3117
D00463
D0M9DC
Danoprox
Daypro (TN)
Dayrun
DB00991
Deflam
DSSTox_CID_25118
DSSTox_GSID_45118
DSSTox_RID_80684
DTXSID1045118
Durapro
Duraprost
Duraprox (TN)
EINECS 244-296-1
EN300-25629
EU-0100944
FT-0638104
GTPL7252
HE004392
HE274938
HMS1571C22
HMS1922P17
HMS2051L15
HMS2093O08
HMS2098C22
HMS3262N10
HMS3393L15
HMS3652H17
HMS566H22
HSDB 7586
HY-B0808
I14-8703
J-013955
J10396
K-6109
KB-59357
KBio3_001916
KBioGR_001722
KS-00000ULR
KS-5196
Lopac-O-9637
Lopac0_000944
LP00944
LS-100216
lyl)propenoic acid
Maybridge1_008800
MCULE-7099031811
MFCD00215977
MHJ80W9LRB
MLS000759535
MLS001424072
MolPort-000-146-829
NC00214
NCGC00014711
NCGC00014711-01
NCGC00014711-02
NCGC00014711-03
NCGC00014711-04
NCGC00014711-05
NCGC00014711-06
NCGC00014711-07
NCGC00014711-08
NCGC00014711-09
NCGC00014711-10
NCGC00014711-11
NCGC00014711-14
NCGC00094249-01
NCGC00094249-02
NCGC00094249-03
NCGC00094249-04
NCGC00094249-05
NCGC00094249-06
NCGC00094249-07
NCGC00261629-01
NCI310839
NCI60_002681
NCIStruc1_000799
NCIStruc2_000787
NSC 310839
NSC-310839
NSC-758949
NSC310839
NSC758949
O 9637
O0377
OFPXSFXSNFPTHF-UHFFFAOYSA-N
Oprea1_509470
Oxapro
oxaprosin
Oxaprozi
oxaprozin
Oxaprozin (JP15/USAN/INN)
Oxaprozin (JP17/USAN/INN)
Oxaprozin [USAN:BAN:INN:JAN]
Oxaprozin, solid
Oxaprozin, United States Pharmacopeia (USP) Reference Standard
Oxaprozina
Oxaprozina [INN-Spanish]
Oxaprozine
Oxaprozine [INN-French]
Oxaprozinum
Oxaprozinum [INN-Latin]
Pfizer brand of oxaprozin
Pharmakon1600-01505267
Prestwick0_001060
Prestwick1_001060
Prestwick2_001060
Prestwick3_001060
Rhoxal-oxaprozin
Rhoxalpharma brand of oxaprozin
s4230
SAM001246770
SBB053166
SBI-0050918.P002
SC-13926
SCHEMBL3286
SMR000058286
SPBio_001652
SPBio_002940
SPECTRUM1505267
Spectrum2_001696
Spectrum3_001078
Spectrum4_001231
SR-01000076053-3
ST50949623
TC-152122
Tox21_110059
Tox21_110059_1
Tox21_500944
TRB brand of oxaprozin
UNII-MHJ80W9LRB
Voir
Walix
WY 21743
WY-21,743
WY-21743
Xopane
Z217102860
ZINC49643479

US Patents and Regulatory Information for DAYPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle DAYPRO oxaprozin TABLET;ORAL 018841-004 Oct 29, 1992 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle DAYPRO ALTA oxaprozin potassium TABLET;ORAL 020776-001 Oct 17, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Federal Trade Commission
Chubb
Argus Health
Queensland Health
QuintilesIMS
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.